Founded in 2011, Lilac Insights operates in Health Tech offering comprehensive genetic health assessments and diagnostics. The company serves over 100 cities in India with its main laboratory and head...
Funding stage:
Venture Round
Last funding:
22/02/2021
Total funding:
$6.91 Mn+
Revenue:
Investors
Employee count:
350
Last 90d
350
Last 90d
Web traffic:
2.26K
2.26K
Last 30d
Last 30d
Glassdoor Rating:
Lilac Insights: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders57
Latest Filing Date02 Nov 2025- Funding Events26
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Lilac Insights
As of 03 November 2025, Lilac Insights's equity is held by 56 shareholders, with the top three being Tara India Fund Iv Trust, Gulshan Haresh Bakhtiani, and Rakesh Kumar Sharma.
Tara India Fund Iv Trust holds the largest stake in Lilac Insights at 29.3% as of 03 November 2025.
As of 03 November 2025, founders collectively hold 45.3% equity in Lilac Insights.
As of 03 November 2025, investors collectively hold 50.4% equity in Lilac Insights.
Lilac Insights's ESOP pool stands at 1.9% of total equity as of 03 November 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links